Global Therapeutic Drug Monitoring Test Market Insights, Forecast to 2028
Table of Contents
1 Report Business Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Therapeutic Drug Monitoring Test Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Blood Test
- 1.2.3 Urine Test
- 1.2.4 Saliva Test
- 1.2.5 Other Test
- 1.3 Market by Application
- 1.3.1 Global Therapeutic Drug Monitoring Test Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Hospital Labs
- 1.3.3 Private Labs
- 1.3.4 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Therapeutic Drug Monitoring Test Market Perspective (2017-2028)
- 2.2 Therapeutic Drug Monitoring Test Growth Trends by Region
- 2.2.1 Therapeutic Drug Monitoring Test Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Therapeutic Drug Monitoring Test Historic Market Size by Region (2017-2022)
- 2.2.3 Therapeutic Drug Monitoring Test Forecasted Market Size by Region (2023-2028)
- 2.3 Therapeutic Drug Monitoring Test Market Dynamics
- 2.3.1 Therapeutic Drug Monitoring Test Industry Trends
- 2.3.2 Therapeutic Drug Monitoring Test Market Drivers
- 2.3.3 Therapeutic Drug Monitoring Test Market Challenges
- 2.3.4 Therapeutic Drug Monitoring Test Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Therapeutic Drug Monitoring Test Players by Revenue
- 3.1.1 Global Top Therapeutic Drug Monitoring Test Players by Revenue (2017-2022)
- 3.1.2 Global Therapeutic Drug Monitoring Test Revenue Market Share by Players (2017-2022)
- 3.2 Global Therapeutic Drug Monitoring Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by Therapeutic Drug Monitoring Test Revenue
- 3.4 Global Therapeutic Drug Monitoring Test Market Concentration Ratio
- 3.4.1 Global Therapeutic Drug Monitoring Test Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Drug Monitoring Test Revenue in 2021
- 3.5 Therapeutic Drug Monitoring Test Key Players Head office and Area Served
- 3.6 Key Players Therapeutic Drug Monitoring Test Product Solution and Service
- 3.7 Date of Enter into Therapeutic Drug Monitoring Test Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Therapeutic Drug Monitoring Test Breakdown Data by Type
- 4.1 Global Therapeutic Drug Monitoring Test Historic Market Size by Type (2017-2022)
- 4.2 Global Therapeutic Drug Monitoring Test Forecasted Market Size by Type (2023-2028)
5 Therapeutic Drug Monitoring Test Breakdown Data by Application
- 5.1 Global Therapeutic Drug Monitoring Test Historic Market Size by Application (2017-2022)
- 5.2 Global Therapeutic Drug Monitoring Test Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America Therapeutic Drug Monitoring Test Market Size (2017-2028)
- 6.2 North America Therapeutic Drug Monitoring Test Market Size by Type
- 6.2.1 North America Therapeutic Drug Monitoring Test Market Size by Type (2017-2022)
- 6.2.2 North America Therapeutic Drug Monitoring Test Market Size by Type (2023-2028)
- 6.2.3 North America Therapeutic Drug Monitoring Test Market Share by Type (2017-2028)
- 6.3 North America Therapeutic Drug Monitoring Test Market Size by Application
- 6.3.1 North America Therapeutic Drug Monitoring Test Market Size by Application (2017-2022)
- 6.3.2 North America Therapeutic Drug Monitoring Test Market Size by Application (2023-2028)
- 6.3.3 North America Therapeutic Drug Monitoring Test Market Share by Application (2017-2028)
- 6.4 North America Therapeutic Drug Monitoring Test Market Size by Country
- 6.4.1 North America Therapeutic Drug Monitoring Test Market Size by Country (2017-2022)
- 6.4.2 North America Therapeutic Drug Monitoring Test Market Size by Country (2023-2028)
- 6.4.3 United States
- 6.4.4 Canada
7 Europe
- 7.1 Europe Therapeutic Drug Monitoring Test Market Size (2017-2028)
- 7.2 Europe Therapeutic Drug Monitoring Test Market Size by Type
- 7.2.1 Europe Therapeutic Drug Monitoring Test Market Size by Type (2017-2022)
- 7.2.2 Europe Therapeutic Drug Monitoring Test Market Size by Type (2023-2028)
- 7.2.3 Europe Therapeutic Drug Monitoring Test Market Share by Type (2017-2028)
- 7.3 Europe Therapeutic Drug Monitoring Test Market Size by Application
- 7.3.1 Europe Therapeutic Drug Monitoring Test Market Size by Application (2017-2022)
- 7.3.2 Europe Therapeutic Drug Monitoring Test Market Size by Application (2023-2028)
- 7.3.3 Europe Therapeutic Drug Monitoring Test Market Share by Application (2017-2028)
- 7.4 Europe Therapeutic Drug Monitoring Test Market Size by Country
- 7.4.1 Europe Therapeutic Drug Monitoring Test Market Size by Country (2017-2022)
- 7.4.2 Europe Therapeutic Drug Monitoring Test Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific Therapeutic Drug Monitoring Test Market Size (2017-2028)
- 8.2 Asia-Pacific Therapeutic Drug Monitoring Test Market Size by Type
- 8.2.1 Asia-Pacific Therapeutic Drug Monitoring Test Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific Therapeutic Drug Monitoring Test Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific Therapeutic Drug Monitoring Test Market Share by Type (2017-2028)
- 8.3 Asia-Pacific Therapeutic Drug Monitoring Test Market Size by Application
- 8.3.1 Asia-Pacific Therapeutic Drug Monitoring Test Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific Therapeutic Drug Monitoring Test Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific Therapeutic Drug Monitoring Test Market Share by Application (2017-2028)
- 8.4 Asia-Pacific Therapeutic Drug Monitoring Test Market Size by Region
- 8.4.1 Asia-Pacific Therapeutic Drug Monitoring Test Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific Therapeutic Drug Monitoring Test Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America Therapeutic Drug Monitoring Test Market Size (2017-2028)
- 9.2 Latin America Therapeutic Drug Monitoring Test Market Size by Type
- 9.2.1 Latin America Therapeutic Drug Monitoring Test Market Size by Type (2017-2022)
- 9.2.2 Latin America Therapeutic Drug Monitoring Test Market Size by Type (2023-2028)
- 9.2.3 Latin America Therapeutic Drug Monitoring Test Market Share by Type (2017-2028)
- 9.3 Latin America Therapeutic Drug Monitoring Test Market Size by Application
- 9.3.1 Latin America Therapeutic Drug Monitoring Test Market Size by Application (2017-2022)
- 9.3.2 Latin America Therapeutic Drug Monitoring Test Market Size by Application (2023-2028)
- 9.3.3 Latin America Therapeutic Drug Monitoring Test Market Share by Application (2017-2028)
- 9.4 Latin America Therapeutic Drug Monitoring Test Market Size by Country
- 9.4.1 Latin America Therapeutic Drug Monitoring Test Market Size by Country (2017-2022)
- 9.4.2 Latin America Therapeutic Drug Monitoring Test Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Therapeutic Drug Monitoring Test Market Size (2017-2028)
- 10.2 Middle East & Africa Therapeutic Drug Monitoring Test Market Size by Type
- 10.2.1 Middle East & Africa Therapeutic Drug Monitoring Test Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa Therapeutic Drug Monitoring Test Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa Therapeutic Drug Monitoring Test Market Share by Type (2017-2028)
- 10.3 Middle East & Africa Therapeutic Drug Monitoring Test Market Size by Application
- 10.3.1 Middle East & Africa Therapeutic Drug Monitoring Test Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa Therapeutic Drug Monitoring Test Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa Therapeutic Drug Monitoring Test Market Share by Application (2017-2028)
- 10.4 Middle East & Africa Therapeutic Drug Monitoring Test Market Size by Country
- 10.4.1 Middle East & Africa Therapeutic Drug Monitoring Test Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa Therapeutic Drug Monitoring Test Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 Roche
- 11.1.1 Roche Company Details
- 11.1.2 Roche Business Overview
- 11.1.3 Roche Therapeutic Drug Monitoring Test Introduction
- 11.1.4 Roche Revenue in Therapeutic Drug Monitoring Test Business (2017-2022)
- 11.1.5 Roche Recent Developments
- 11.2 Danaher
- 11.2.1 Danaher Company Details
- 11.2.2 Danaher Business Overview
- 11.2.3 Danaher Therapeutic Drug Monitoring Test Introduction
- 11.2.4 Danaher Revenue in Therapeutic Drug Monitoring Test Business (2017-2022)
- 11.2.5 Danaher Recent Developments
- 11.3 Abbott
- 11.3.1 Abbott Company Details
- 11.3.2 Abbott Business Overview
- 11.3.3 Abbott Therapeutic Drug Monitoring Test Introduction
- 11.3.4 Abbott Revenue in Therapeutic Drug Monitoring Test Business (2017-2022)
- 11.3.5 Abbott Recent Developments
- 11.4 Thermo Fisher Scientific
- 11.4.1 Thermo Fisher Scientific Company Details
- 11.4.2 Thermo Fisher Scientific Business Overview
- 11.4.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Test Introduction
- 11.4.4 Thermo Fisher Scientific Revenue in Therapeutic Drug Monitoring Test Business (2017-2022)
- 11.4.5 Thermo Fisher Scientific Recent Developments
- 11.5 Siemens Healthcare
- 11.5.1 Siemens Healthcare Company Details
- 11.5.2 Siemens Healthcare Business Overview
- 11.5.3 Siemens Healthcare Therapeutic Drug Monitoring Test Introduction
- 11.5.4 Siemens Healthcare Revenue in Therapeutic Drug Monitoring Test Business (2017-2022)
- 11.5.5 Siemens Healthcare Recent Developments
- 11.6 Bio-Rad Laboratories
- 11.6.1 Bio-Rad Laboratories Company Details
- 11.6.2 Bio-Rad Laboratories Business Overview
- 11.6.3 Bio-Rad Laboratories Therapeutic Drug Monitoring Test Introduction
- 11.6.4 Bio-Rad Laboratories Revenue in Therapeutic Drug Monitoring Test Business (2017-2022)
- 11.6.5 Bio-Rad Laboratories Recent Developments
- 11.7 BioMerieux
- 11.7.1 BioMerieux Company Details
- 11.7.2 BioMerieux Business Overview
- 11.7.3 BioMerieux Therapeutic Drug Monitoring Test Introduction
- 11.7.4 BioMerieux Revenue in Therapeutic Drug Monitoring Test Business (2017-2022)
- 11.7.5 BioMerieux Recent Developments
- 11.8 Sanquin
- 11.8.1 Sanquin Company Details
- 11.8.2 Sanquin Business Overview
- 11.8.3 Sanquin Therapeutic Drug Monitoring Test Introduction
- 11.8.4 Sanquin Revenue in Therapeutic Drug Monitoring Test Business (2017-2022)
- 11.8.5 Sanquin Recent Developments
- 11.9 Becton Dickinson
- 11.9.1 Becton Dickinson Company Details
- 11.9.2 Becton Dickinson Business Overview
- 11.9.3 Becton Dickinson Therapeutic Drug Monitoring Test Introduction
- 11.9.4 Becton Dickinson Revenue in Therapeutic Drug Monitoring Test Business (2017-2022)
- 11.9.5 Becton Dickinson Recent Developments
- 11.10 Quest Diagnostics
- 11.10.1 Quest Diagnostics Company Details
- 11.10.2 Quest Diagnostics Business Overview
- 11.10.3 Quest Diagnostics Therapeutic Drug Monitoring Test Introduction
- 11.10.4 Quest Diagnostics Revenue in Therapeutic Drug Monitoring Test Business (2017-2022)
- 11.10.5 Quest Diagnostics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
Summary:
Market Analysis and Insights: Global Therapeutic Drug Monitoring Test Market
The global Therapeutic Drug Monitoring Test market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Blood Test accounting for % of the Therapeutic Drug Monitoring Test global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Labs segment is altered to an % CAGR throughout this forecast period.
China Therapeutic Drug Monitoring Test market size is valued at US$ million in 2021, while the North America and Europe Therapeutic Drug Monitoring Test are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Therapeutic Drug Monitoring Test landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Therapeutic Drug Monitoring Test market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Therapeutic Drug Monitoring Test market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Therapeutic Drug Monitoring Test market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Therapeutic Drug Monitoring Test market.
Impact of Covid-19 Outbreak
This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
Segmental Analysis
The report has been segmented into product and application segments. The researchers have documented all the products present today in the Therapeutic Drug Monitoring Test market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
Therapeutic Drug Monitoring Test Breakdown Data by Type
Blood Test
Urine Test
Saliva Test
Other Test
Therapeutic Drug Monitoring Test Breakdown Data by Application
Hospital Labs
Private Labs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
Roche
Danaher
Abbott
Thermo Fisher Scientific
Siemens Healthcare
Bio-Rad Laboratories
BioMerieux
Sanquin
Becton Dickinson
Quest Diagnostics
Frequently Asked Questions
What factors will challenge the Therapeutic Drug Monitoring Test market growth?
Which end-use segment will expand at the fastest CAGR in the Therapeutic Drug Monitoring Test market?
Which are the emerging players in the Therapeutic Drug Monitoring Test market?
How concentrated is the Therapeutic Drug Monitoring Test market?
Which factors are positively contributing to the Therapeutic Drug Monitoring Test market growth?
Which are the novel product innovations in the Therapeutic Drug Monitoring Test market?
Which product segment will emerge as the most lucrative in the Therapeutic Drug Monitoring Test market?
Which factors are increasing the competition in the Therapeutic Drug Monitoring Test market?
Which are the strategic measures taken by the Therapeutic Drug Monitoring Test industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Therapeutic Drug Monitoring Test market in the coming years?